You searched for "ophthalmoplegia"
How much money is wasted on tests prior to cataract surgery? And why?
For routine cataract surgery, numerous studies have found that preoperative testing does not contribute usefully to safety or surgical success. Despite such guidelines, tests ordered for patients prior to phacoemulsification in the US remains high. To quantify the associated costs,...
Can intravitreal anti-VEGF injections affect corneal nerves?
This was a retrospective case-control study looking at the effect of anti-VEGF injections on corneal nerves (CN). Fifty-seven patients with a history of at least three anti-VEGF injections in one or both eyes and available confocal microscopic imaging were included...Haag-Streit UK looks forward to exhibiting at the RCOphth Annual Congress 2023
Haag-Streit UK is pleased to announce it will be exhibiting at Royal College of Ophthalmologists (RCOphth) Annual Congress on 22-25 May 2023 at the ICC in Birmingham.Haag-Streit Academy 2024 course schedule released – book your place now!
Haag-Streit Academy is pleased to launch it’s 2024 course schedule. The schedule features our popular CPD-accredited training and education events which include informative lectures and practical, hands-on workshops, delivered by industry experts.30 Years of Excellence: Surgitrac Instruments at the 42nd ESCRS Congress
Surgitrac Instruments proudly participated in the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) this September, celebrating 30 years of heritage. The congress was the ideal opportunity to showcase our expertise in manufacturing and supplying high-quality...Haag-Streit UK relaunches the Perkins Mk 3 hand-held applanation tonometer
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce that they have relaunched the Perkins Mk 3 hand-held applanation tonometer. Haag-Streit UK discontinued the...Glaukos Launches iStent infinite® in the UK Following MDR Approval
Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...
